SCHEMBL7348151

SCHEMBL7348151

OC[C@H](Cc1ccccc1)N[C@H](CO)Cc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.58
CYP3A4 P08684 1/20 0.58
KMT2A Q03164 2/20 0.56
KDM4E B2RXH2 1/20 0.56
MEN1 O00255 1/20 0.56
MAPT P10636 1/20 0.56
TRPA1 O75762 1/20 0.54
EPHX1 P07099 2/20 0.52
SIGMAR1 Q99720 1/20 0.48
ROCK2 O75116 1/20 0.47
RPS6KA5 O75582 1/20 0.47
RPS6KA4 O75676 1/20 0.47
PRKACA P17612 1/20 0.47
GSK3A P49840 1/20 0.47
GSK3B P49841 1/20 0.47
IRAK1 P51617 1/20 0.47
PRKX P51817 1/20 0.47
ROCK1 Q13464 1/20 0.47
PRKG1 Q13976 1/20 0.47
PKN2 Q16513 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7345520 1.00 MAPK1 (0.58) MAPK1CYP3A4KMT2AKDM4EMEN1
SCHEMBL7444929 0.90 CYP3A4 (0.58) MAPK1CYP3A4KMT2AKDM4EMEN1
SCHEMBL6673196 0.90 CYP3A4 (0.58) MAPK1CYP3A4KMT2AKDM4EMEN1
SCHEMBL6673198 0.90 CYP3A4 (0.58) MAPK1CYP3A4KMT2AKDM4EMEN1
Hydrochloric Acid SCHEMBL10879916 0.88 CYP3A4 (0.57) MAPK1CYP3A4KMT2AKDM4EMEN1
Hydrochloric Acid SCHEMBL10998387 0.88 CYP3A4 (0.57) MAPK1CYP3A4KMT2AKDM4EMEN1
SCHEMBL18435245 0.87 CYP3A4 (0.55) MAPK1CYP3A4KMT2AKDM4EMEN1
SCHEMBL18435381 0.87 CYP3A4 (0.55) MAPK1CYP3A4KMT2AKDM4EMEN1
SCHEMBL18332505 0.86 MAPK1 (0.54) MAPK1CYP3A4KMT2AKDM4EMEN1
SCHEMBL7350419 0.86 MAPK1 (0.54) MAPK1CYP3A4KMT2AKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5389647-A A prodrugs as hypotensive agents, treating congestive heart failure, urogenital disorders, vision defects ABBOTT LABORATORIES (US) 1995-02-14 US disclosed
WO-1992003429-A1 RENIN INHIBITORS ABBOTT LABORATORIES (US) 1992-03-05 WO disclosed